Trial · NCT03161093
Adverse events1,326
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 1,326
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Arthralgia | Musculoskeletal and connective tissue disorders | Placebo | 76 | 352 | 117 |
| other | Arthralgia | Musculoskeletal and connective tissue disorders | Naproxen | 232 | 1,056 | 357 |
| other | Arthralgia | Musculoskeletal and connective tissue disorders | Fasinumab 1mg Q8W | 152 | 554 | 228 |
| other | Arthralgia | Musculoskeletal and connective tissue disorders | Fasinumab 1mg Q4W | 284 | 1,052 | 467 |
| other | Arthralgia | Musculoskeletal and connective tissue disorders | Fasinumab 3mg Q4W | 13 | 145 | 16 |
| other | Arthralgia | Musculoskeletal and connective tissue disorders | Fasinumab 6mg Q8W | 30 | 139 | 42 |
| other | Back pain | Musculoskeletal and connective tissue disorders | Placebo | 39 | 352 | 51 |
| other | Back pain | Musculoskeletal and connective tissue disorders | Naproxen | 117 | 1,056 | 160 |
| other | Back pain | Musculoskeletal and connective tissue disorders | Fasinumab 1mg Q8W | 83 | 554 | 112 |
| other | Back pain | Musculoskeletal and connective tissue disorders | Fasinumab 1mg Q4W | 124 | 1,052 | 155 |
| other | Back pain | Musculoskeletal and connective tissue disorders | Fasinumab 3mg Q4W | 4 | 145 | 5 |
| other | Back pain | Musculoskeletal and connective tissue disorders | Fasinumab 6mg Q8W | 4 | 139 | 5 |
| other | Pain in extremity | Musculoskeletal and connective tissue disorders | Placebo | 20 | 352 | 27 |
| other | Pain in extremity | Musculoskeletal and connective tissue disorders | Naproxen | 62 | 1,056 | 82 |
| other | Pain in extremity | Musculoskeletal and connective tissue disorders | Fasinumab 1mg Q8W | 34 | 554 | 41 |
| other | Pain in extremity | Musculoskeletal and connective tissue disorders | Fasinumab 1mg Q4W | 65 | 1,052 | 88 |
| other | Pain in extremity | Musculoskeletal and connective tissue disorders | Fasinumab 3mg Q4W | 2 | 145 | 2 |
| other | Pain in extremity | Musculoskeletal and connective tissue disorders | Fasinumab 6mg Q8W | 3 | 139 | 4 |
| other | Osteoarthritis | Musculoskeletal and connective tissue disorders | Placebo | 18 | 352 | 23 |
| other | Osteoarthritis | Musculoskeletal and connective tissue disorders | Naproxen | 34 | 1,056 | 41 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03161093/events